An expert panel’s final report on the fatal drug trial earlier this year in France states that the death of...
Up To Date
Latest News
For up to US$685m (€606m), Dutch ArgenX has outlicensed its human antibody programme ARGX-115 to AbbVie. The...
Despite political disturbances, 2015 was a good year for the biotech scene in Switzerland. Net sales increased...
Recipharm remains on track for growth. The Swedish CDMO is acquiring Italian injectable beta lactam expert...